These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 205312)

  • 21. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
    Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vincristine neuropathy: an electrophysiological and histological study.
    McLeod JG; Penny R
    J Neurol Neurosurg Psychiatry; 1969 Aug; 32(4):297-304. PubMed ID: 4309019
    [No Abstract]   [Full Text] [Related]  

  • 23. [The early phase of vincristine-induced neuropathy. Electrophysiological evidence of a "dying-back" phenomenon (author's transl)].
    Sebille A; Parlier Y
    Nouv Presse Med; 1981 Jul; 10(29):2417-20. PubMed ID: 6265865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and electrophysiological studies in vincristine induced neuropathy.
    Pal PK
    Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinico-electrophysiological study of vincristine neuropathy. Study of 6 leukemic children].
    Ferrante E; Savino A
    Riv Neurol; 1990; 60(3):131-6. PubMed ID: 1964745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological Studies to Detect Peripheral Neuropathy in Children Treated With Vincristine.
    Kavcic M; Koritnik B; Krzan M; Velikonja O; Prelog T; Stefanovic M; Debeljak M; Jazbec J
    J Pediatr Hematol Oncol; 2017 May; 39(4):266-271. PubMed ID: 28375940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vincristine-induced peripheral neuropathy in a dog.
    Hamilton TA; Cook JR; Braund KG; Morrison WB; Mehta JR
    J Am Vet Med Assoc; 1991 Feb; 198(4):635-8. PubMed ID: 1850399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat.
    Sweitzer SM; Pahl JL; DeLeo JA
    Neurosci Lett; 2006 Jun; 400(3):258-61. PubMed ID: 16530953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vincristine neuropathy with bowel and bladder atony, mimicking spinal cord compression.
    Raphaelson MI; Stevens JC; Newman RP
    Cancer Treat Rep; 1983 Jun; 67(6):604-5. PubMed ID: 6305500
    [No Abstract]   [Full Text] [Related]  

  • 30. Experience with vincristine--associated neurotoxicity.
    Othieno-Abinya NA; Nyabola LO
    East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy.
    Ozyurek H; Turker H; Akbalik M; Bayrak AO; Ince H; Duru F
    Pediatr Hematol Oncol; 2007 Sep; 24(6):447-52. PubMed ID: 17710662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of vincristine-induced neuropathy in lymphomas.
    Watkins SM; Griffin JP
    Br Med J; 1978 Mar; 1(6113):610-2. PubMed ID: 630255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vincristine neurotoxicity.
    Hildebrand J; Kenis Y; Mubashir BA; Bart JB
    N Engl J Med; 1972 Sep; 287(10):517. PubMed ID: 4340238
    [No Abstract]   [Full Text] [Related]  

  • 34. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
    Schiavetti A; Frascarelli M; Uccini S; Novelli A
    Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population.
    Gutierrez-Camino A; Martin-Guerrero I; Lopez-Lopez E; Echebarria-Barona A; Zabalza I; Ruiz I; Guerra-Merino I; Garcia-Orad A
    Pharmacogenet Genomics; 2016 Feb; 26(2):100-2. PubMed ID: 26618658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study.
    Zgheib NK; Ghanem KM; Tamim H; Aridi C; Shahine R; Tarek N; Saab R; Abboud MR; El-Solh H; Muwakkit SA
    Pharmacogenet Genomics; 2018 Aug; 28(8):189-195. PubMed ID: 30119132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
    van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
    Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additive toxicity of vincristine and other drugs for the peripheral nervous system. Three case reports.
    Hildebrand J; Kenis Y
    Acta Neurol Belg; 1971; 71(6):486-91. PubMed ID: 4336078
    [No Abstract]   [Full Text] [Related]  

  • 39. Augmentation of vincristine neurotoxicity by irradiation of peripheral nerves.
    Cassady JR; Tonnesen GL; Wolfe LC; Sallan SE
    Cancer Treat Rep; 1980; 64(8-9):963-5. PubMed ID: 6256075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
    Weintraub M; Adde MA; Venzon DJ; Shad AT; Horak ID; Neely JE; Seibel NL; Gootenberg J; Arndt C; Nieder ML; Magrath IT
    J Clin Oncol; 1996 Mar; 14(3):935-40. PubMed ID: 8622042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.